1. Thomas PD, Hunninghake. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135:747-760
2. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336:1224-1234
3. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997; 18:755-785
   
4. Sones M, Isreal HL. Course and prognosis of sarcoidosis. Am J Med 1960; 29:84-93
   
5. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Quart J Med 1983; 208:525-533
   
6. Mana J, Salazar A, Manresa F. Clinical factor predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994; 61:219-225
   
7. Huang CT, Heurich AE, Sutton AL, Lyons HA. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981;62:231-238
   
8. Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 1987; 92:505-508
   
9. Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med 1997; 18:853-864
   
10. Isreal HI, Karlin P, Menduke H. Factors affecting outcome of sarcoidosis. Ann NY Acad Sci 1986; 465:395-406
    
11. Scheffield EA. Pathology of sarcoidosis. Clin Chest Med 1997; 18:741-754
    
12. Dawson WB, Muller NL. High-resolution computed tomography in pulmonary sarcoidosis. Sem Ultrasound, CT, MR. 1990; 11:423-429
    
13. Puar HS, Young RC, Armstrong EM. Bronchial and transbronchial biopsy without fluoroscopy in sarcoidosis. Chest 1985; 87;303-306
    
14. Bjermer L, Thunell M, Rosenhall L, Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85:229-234
    
15. Iles PB. Multiple bronchial stenoses: treatment by mechanical dilatation. Thorax 1981; 36:784-786
    
16. Winterbauer RH, Belic N, Moores KD. A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 78:65-71
    
17. Udwadia ZF, Pilling JR, Jenkins PF, Harrison BDW. Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 1990; 45:272-275
    
18. Hoffstein V, Ranganathan N, Mullen JB. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986; 134:809-811
    
19. Highland KB, Retalis P, Coppage L, Schabel SI, Judson MA. Is there an anatomic explanation for chest Pain in patients with pulmonary sarcoidosis? So Med J 1997; 90:911-914
    
20. Baughman RP, Shipley RT, Loudon RG, Lower EE. Crackles in interstitial lung disease: comparison of sarcoidosis and fibrosing alveolitis. Chest 1991; 100:96-101
    
21. Niimi H, Kang EY, Kwong JS, Carignan S, Muller NL. CT of chronic infiltrative lung disease: prevalence of mediastinal adenopathy. J Comput Assist Tomogr 1996; 20:305-308
    
22. Siltzback LE. Sarcoidosis: clinical features and management. Med Clin NA 1967; 51:483-502
    
23. Romer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 1982; 29:27-32
    
24. Brauner MW, Lenoir S, Grenier P, Cluzel P, et al. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992; 182:349-354
    
25. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest 1980; 78:640-647
    
26. Suddeth CD, Sahn SA. Airways obstruction in sarcoidosis. Pulmonary Crit Care Update 1991; 7:1-6
    
27. Meyer KC. Beryllium and lung disease. Chest 1994; 106:942-946
    
28. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122:721-724
    
29. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H, and the ACCESS Research Group. Sarcoidosis Vasc Diff Lung Dis 1999;16:75-86
    
30. Hiraga Y, Hosoda Y. Acceptability of epidemiological diagnostic criteria for sarcoidosis without histologic confirmation, eds. R. Mikami, Y Hosoda. In: Sarcoidosis. Tokyo: University of Tokyo Press, pp 373-377
    
31. Allen RK. A review of angiotensin converting enzyme in health and disease. Sarcoidosis 1991; 8:95-100
    
32. Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK, Harrison BDW. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51:238-247
    
33. Winterbauer RH, Kirtland SH, Corley DE. Treatment with corticosteroids. Clin Chest Med 1997; 18:843-851
    
34. Isreal HL, Fouts DW, Beggs RA. A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 1973; 107:609-614
    
35. Seleroos O, Sellergren TL. Corticosteroid therapy of pulmonary sarcoidosis. Scand J Resp Dis 1979; 60:215-221
36. Zaki MH, Lyons HA, Leilop L, Huang CT. Corticosteroid therapy in sarcoidosis. NY State J Med 1987; 87:496-499
    
37. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE. Pulmonary sarcoidosis. Chest 1982; 82:84-87
    
38. Gottlieb JE, Isreal HL, Steiner RM, Patrick H. Outcome in sarcoidosis. Chest 1997; 111:623-631
    
39. Sharma OP. Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis 1993; 147:1598-1600
    
40. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, Merchant R, Wilson J, Galvin J, Schwartz D. Outcome of treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149:893-898
    
41. Huang CT, Heurich AE, Sutton AL, Lyons HA. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981;62:231-238
    
42. Selroos O, Sellergren TL. Corticosteroid therapy of pulmonary sarcoidosis. Scand J Resp Dis 1979; 60:215-221
    
43. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA. Immunohistochemical localization of transforming growth factor-beta1 in the non necrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:197-204
    
44. DeRemee RA. The present status of treatment of pulmonary sarcoidosis: a house divided. Cjest 1977; 71:388-393
    
45. Johns CJ, MacGregor MI, Zachary JB, et al. Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis. NY Acad Sci 1976; 278:722-731
    
46. Johns CJ, Schonfeld SA, Scott PP, Zachary JB, MacGregor MI. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroids. Ann NY Acad Sci 1986; 465:702-712
    
47. Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev respir Dis 1990; 142:1268-1271
    
48. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-851
    
49. Sharma O, Hughes DTD, James DG, et al. Immunosuppressive therapy with azathioprine in sarcoidosis. Fifth International Conference on Sarcoidosis. Prague: Universita Karlova, 1971:635-637
    
50. Pacheco Y, Marechal C, Marechal F, et al. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis 1985; 2:107-113
    
51. Zabel P, Entzian P, Dalhoff K, et al. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 1997;155:1665-1669
    
52. Kataria YP. Chlorambucil in sarcoidosis. Chest 1980; 78:36-43
    
53. Isreal HL, McComb BL. Chlorambucil treatment of sarcoidosis. Sarcoidosis. 1991; 8:35-41
    
54. Jones E, Cagen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. Am Acad Dermatol 1990; 23:487-489
    
55. Spiteri MA, Newman SP, Clarke SW, et al. Inhaled corticosteroids can modulate the immunopathogenesis of pulmonary sarcoidosis. Eur Respir j 1989; 2:218-224
    
56. Seleroos O, Lofroos A, Pietinalho A, et al. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis. Sarcoidosis 1994; 11:126-131
    
57. Seleroos O. Use of budesonide in the treatment of pulmonary sarcoidosis. Ann NY Acad Sci 1986; 465:713-721
    
58. Pietinalho A. Inhaled corticosteroid therapy in pulmonary sarcoidosis. Sarcoidosis 1991; 8:168-169
    
59. Alberts C, Van der Mark TW, Jansen HM, et al. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J 1995; 8:682-688
    
60. Zych D, Pawlicka L, Zielinski J. Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis. Sarcoidosis 1993; 10:56-61
    
61. Gupta SK. Treatment of sarcoidosis patients by steroid aerosol: a 10-year prospective study from eastern India. Sarcoidosis 1989; 6:51-54
    
62. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O, Finnish Sarcoidosis Study Group. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis. Chest 1999; 116:424-431
    
63. Milman N, Graudal N, Grode G, et al. No effect of high dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study. J Intern Med 1994; 236:285-290
    

     Physician Information Page

disclaimer